Xencor (XNCR) Share-based Compensation (2013 - 2026)

Xencor (XNCR) reported Share-based Compensation of $9.6 million for Q1 2026, down 21.71% year-over-year from $12.2 million in Q1 2025, and down 6.13% quarter-over-quarter from $10.2 million in Q4 2025.

Xencor (XNCR) Share-based Compensation (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Share-based Compensation data on file, last reported at $9.6 million in Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $9.6 million, down 21.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.6 million (down 24.96% YoY), and the FY2025 annual result was $43.2 million, down 18.87% from the prior year.
  • Share-based Compensation fell to $9.6 million in Q1 2026 per XNCR's latest filing, from $10.2 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $17.2 million in Q2 2024 and troughed at $9.6 million in Q1 2026.
  • A 5-year average of $12.3 million and a median of $12.3 million in 2024 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2025: Share-based Compensation soared 42.68% in 2022, then plunged 37.54% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $12.7 million in 2022, then increased by 15.32% to $14.7 million in 2023, then retreated by 16.09% to $12.3 million in 2024, then dropped by 17.41% to $10.2 million in 2025, then decreased by 6.13% to $9.6 million in 2026.
  • Business Quant data shows XNCR's Share-based Compensation at $9.6 million in Q1 2026, $10.2 million in Q4 2025, and $10.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Xencor 953.38 Mn 878.64 Mn - 9.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.56 Mn
Mar 31, 2026 9.56 Mn
Dec 31, 2025 10.19 Mn
Dec 31, 2025 10.19 Mn
Sep 30, 2025 10.09 Mn
Sep 30, 2025 10.09 Mn
Jun 30, 2025 10.74 Mn
Jun 30, 2025 10.74 Mn
Mar 31, 2025 12.21 Mn
Mar 31, 2025 12.21 Mn
Dec 31, 2024 12.33 Mn
Dec 31, 2024 12.33 Mn
Sep 30, 2024 12.34 Mn
Sep 30, 2024 12.34 Mn
Jun 30, 2024 17.19 Mn
Jun 30, 2024 17.19 Mn
Mar 31, 2024 11.42 Mn
Mar 31, 2024 11.42 Mn
Dec 31, 2023 14.70 Mn
Dec 31, 2023 14.70 Mn